Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Bio-Path Holdings (BPTH) has issued an announcement.
Bio-Path Holdings, Inc. recently announced their presentation of promising data from a Phase 2 study exploring the use of Prexigebersen in treating Acute Myeloid Leukemia. This significant development was shared at the esteemed European Hematology Association Congress, showcasing the company’s progress in the field of cancer treatment.
See more data about BPTH stock on TipRanks’ Stock Analysis page.